BioSpace News Archive

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, at 2:50 p.m. Eastern Time.

Vertex Pharmaceuticals Incorporated announced that Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in two upcoming investor conferences: TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 at 10:30 a.m. ET.

GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today reported its financial results for the fourth quarter and full year of 2023.

Ono Pharmaceutical Co., Ltd. announced that it has entered into a research collaboration agreement with InveniAI® LLC, to identify novel therapeutic targets by leveraging cutting-edge InveniAI’s artificial intelligence and machine learning.

Omeros Corporation (Nasdaq: OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA).

Hox Therapeutics Ltd (“Hox”) a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd (“Vernalis”), a fully owned subsidiary of HitGen Inc., are pleased to announce a collaboration to identify inhibitors against an undisclosed oncology target.

Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, announced a Series C Financing close in excess of $30M. U.S. Venture Partners, led the round.

Brain-based impairments in memory, reasoning and planning – collectively known as cognitive deficits – are present in several major neuropsychiatric disorders, most notably schizophrenia, affective disorders, autism spectrum disorders and attention-deficit/hyperactivity disorder.

Caira Surgical, the pioneer in Radar Surgical Tracking for robotic and navigated joint replacement surgery, today announced its upcoming participation in the prestigious LSI USA ’24 Emerging Medtech Summit.

Prime Medicine, Inc. announced the closing of its underwritten upsized public offering of 22,560,001 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 3,360,000 additional shares of its common stock.